10/ We shouldn't be afraid of creatinine #ISNWCN #MedSky

@scoca1.bsky.social made it very easy to understand: maybe attach this to every consult?

@glaucomflecken.bsky.social

2/ It was so close... but there was a winner. Curious to see who won? #ISNWCN

Screening criteria per Endocrine society for PA

Contrast with actual screening rates - summarized here pubmed.ncbi.nlm.nih.gov/36965825/ from @ajkd.bsky.social

#ISNWCN #NephSky

10-20% variability in eGFR.

40-50% variability in Albuminuria.

Make your clinical judgment accordingly.👌
#ISNWCN

This is the algorithm he prefers from a 2020 for biopsy and management www.kidney-international.org/article/S008...
2020 @kidneyint.bsky.social - looks #OpenAccess

#ISNWCN #NephSky #Onconeph

Watch this space for biomarkers I say 😎

And we need to play by local rules and those rules say, we need to repost rather than just like. It was okay to be a lurker on #MedTweeter, but here we have to embrace our inner extrovert.

Repost rather than like to help build #MedSky

Some pivot is probably with ICUs and maybe neurgosurgical teams.

So I also added a good rapport with them is also translational. 😜

Of course governments need to make a stronger push. Unless governmental action brings in with stronger effort, I'm not sure what as we nephrologists could do🤷

Tacrolimus search didn't show any result and only cyclosporin did. (I guess because of no binding to cyclophilin).

Alisporivir binds only to cyclophilin and not to calcineurin, hence I assume doesn't have the immunosuppressive action.

On doing literature search, there were few reports mentioning improvements of proteinuria with cyclosporin but most were case reports.

One observational study which studied immunosuppressants (+CysA) didn't show benefit.

It will be interesting to see if it picks up further.

@safety.bsky.app @bsky.app

This looks quite some time back. But I'm able to see all your posts.

Clearly seen.
Is this some sorta prank?🙄

DIPAK. Lanreotide didn't help.